Dr Evan Charles Delancey, DO in Dearborn, MI - Medicare Student in an Organized Health Care Education/Training Program

Dr Evan Charles Delancey, DO is a medicare enrolled "Student In An Organized Health Care Education/training Program" physician in Dearborn, Michigan. His current practice location is 18101 Oakwood Blvd, Dearborn, Michigan. You can reach out to his office (for appointments etc.) via phone at (870) 549-2207.

Dr Evan Charles Delancey is licensed to practice in * (Not Available) (license number ) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1043892581.

Contact Information

	Dr Evan Charles Delancey, DO
	18101 Oakwood Blvd, Dearborn, MI 48124-4089
	(870) 549-2207
	Not Available

Physician's Profile

Full Name	Dr Evan Charles Delancey
Gender	Male
Speciality	Student In An Organized Health Care Education/training Program
Location	18101 Oakwood Blvd, Dearborn, Michigan
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1043892581
Provider Enumeration Date: 04/23/2021
Last Update Date: 08/21/2022

Medicare PECOS Information:

PECOS PAC ID: 7416336086
Enrollment ID: I20220628002385

Medical Identifiers

Medical identifiers for Dr Evan Charles Delancey such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1043892581	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207V00000X	Obstetrics & Gynecology	621854358 (Tennessee)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Evan Charles Delancey is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Evan Charles Delancey, DO 18101 Oakwood Blvd, Dearborn, MI 48124-4089 Ph: () -	Dr Evan Charles Delancey, DO 18101 Oakwood Blvd, Dearborn, MI 48124-4089 Ph: (870) 549-2207

News Archive

Medicare penalties for hospital-acquired infections didn't cut infection rate, study finds

The research, reported in the New England Journal of Medicine, looked at the effect of a 2008 change that cut payments to hospitals for treating infections that patients received while hospitalized.

Do common treatments for ADHD increase risk of drug abuse?

Parents, doctors, and others have wondered whether common treatments for attention-deficit hyperactivity disorder (ADHD) inadvertently predispose adolescents to future drug abuse.

MatrixRIB MIPO instrumentation from DePuy Synthes CMF is more effective for rib fractures

DePuy Synthes CMF, a leader in skeletal and soft tissue repair and reconstruction, announced the launch of new instrumentation that enables less invasive surgical fixation and stabilization of rib fractures with the company's MatrixRIB System of precontoured, low-profile titanium plates, locking screws and intramedullary splints.

SARS-CoV-2 variant B.1.617 may be more transmissible and pathogenic due to spike cleavage

In a new research paper currently available on the bioRxiv* preprint server, a research group from the United Kingdom (UK) provides experimental evidence that B.1.617 lineage of the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) – also known as the Indian variant of concern – shows enhanced cleavage of spike glycoprotein by furin, which can enhance its transmissibility and pathogenic traits.

New approach to turn diseased cells into unique manufacturing sites for treating muscular dystrophy

In a new study that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have adapted a chemical approach to turn diseased cells into unique manufacturing sites for molecules that can treat a form of muscular dystrophy.

Dr Evan Charles Delancey, DO - Medicare Student in an Organized Health Care Education/Training Program in Dearborn, MI